Scientists find a youth protein that helps aging brain cells act young again — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- TIMP2 is identified as a key regulator of microglial health, with its absence causing brain immune cells to develop aging- and injury-like features including reduced debris-clearance ability and molecular signatures of cellular senescence.
- Joseph M. Castellano and colleagues at the Icahn School of Medicine at Mount Sinai published the findings in Nature Communications, using single-nucleus RNA sequencing, imaging, and in vivo microdialysis across multiple mouse models including whole-body and cell-specific TIMP2 knockouts.
- First author Brittany Hemmer, a graduate student in Castellano's lab, was part of the team that showed restoring TIMP2 via injection improved cellular-debris clearance and lowered harmful molecular signatures in older mice.
- Microglia shifted toward inflammatory, potentially damaging states when TIMP2 was removed, and in vivo microdialysis detected higher levels of inflammation- and stress-linked proteins in the surrounding extracellular fluid.
- TIMP2 previously identified by the same group as a regulator of synaptic plasticity via the extracellular matrix, suggesting the protein sits at the intersection of multiple brain-aging processes.
- Researchers caution that results are from mouse experiments and that it remains unknown whether TIMP2 produces similar effects in humans or whether it can be targeted as a treatment for age-related neurological disorders.
- Funding came from the National Institute on Aging (grants including R01AG061382 and RF1AG072300) and the Cure Alzheimer's Fund.
Why it matters: The study names a specific, druggable-looking protein — TIMP2 — whose restoration in older mice reversed measurable hallmarks of brain aging in microglia, the cells most directly implicated in Alzheimer's-linked neuroinflammation. For the ~55 million people living with dementia worldwide, even a mouse-stage finding that links a circulating 'youth factor' to microglial function gives drug-discovery programs a concrete molecular handle rather than a vague association.
Ask SkimNews
